You are here

January/February 2018

The unrelenting growth of diabetes around the world is prompting cardiologists to rethink how they treat and manage a challenging patient population, even as an emerging class of cardio-protective diabetes drugs is setting the stage for transformation.

Nearly ten years ago, a Food and Drug Administration (FDA) advisory panel expressed concern that several novel diabetes therapies carried an increased or at least ambiguous cardiovascular risk and recommended safety testing on all new diabetes drugs. At the time, a number of industry experts predicted that this new guidance would put a chill on the development of glucose-lowering medications for millions of individuals with diabetes. The opposite has occurred. Instead, it  touched off a wave cardiovascular outcomes trials...

Features
When third-grader Ava Rao was diagnosed with type 1 diabetes, it changed life for her whole family. Now a high school freshman, Ava and her dad, cardiologist Sunil V. Rao, MD, share their...
Features
Artificial intelligence (AI)–assisted electrophysiology (EP) shows promise, but even its most ardent advocates aren’t ready for full-fledged endorsement—yet.   
Departments
As Cardiovascular Business enters its second decade, our team has been pondering what the magazine’s pre-teen and teen years will be like. Are we looking at dignified maturity or awkward...
Features
Ensuring mission and money in faculty compensation plans is a tall order for academic medical centers.
Features
Cardiologists are receiving more exposure to different imaging modalities during their fellowships, but their job prospects and training vary widely. A more comprehensive and multimodality training...
Features
The healthcare delivery environment continues to evolve, requiring clinicians and practice executives to seek solutions that will lead to a pathway of success.
Features
Concierge cardiologists report high job satisfaction along with more stable practice revenue, but experts caution specialists to learn about the differences in practice models.   
Departments
Patients want healthcare cost information, but price lists alone aren’t turning them into savvy shoppers.
Features
Understanding risks, policy costs and potential value can help you decide whether to invest in cyber-liability insurance.
Departments
Conversations about compensation are among the toughest for healthcare leaders to navigate. Add accusations of gender bias, and it’s a powder keg.